Click for best price
Pediatric Gastrointestinal Drugs Market Size, Share 2022
This report contains market size and forecasts of Pediatric Gastrointestinal Drugs in Global, including the following market information:
Global Pediatric Gastrointestinal Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pediatric Gastrointestinal Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pediatric Gastrointestinal Drugs include AstraZeneca, Sanofi, Aptalis, Eisai, Pfizer, Zeria (Tillotts), GlaxoSmithKline, Salix Pharmaceuticals and Perrigo, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pediatric Gastrointestinal Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatric Gastrointestinal Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pediatric Gastrointestinal Drugs Market Segment Percentages, by Type, 2021 (%)
Tablets
Pills
Oral Liquid
Global Pediatric Gastrointestinal Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pediatric Gastrointestinal Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Global Pediatric Gastrointestinal Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pediatric Gastrointestinal Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediatric Gastrointestinal Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pediatric Gastrointestinal Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Sanofi
Aptalis
Eisai
Pfizer
Zeria (Tillotts)
GlaxoSmithKline
Salix Pharmaceuticals
Perrigo
Abbott
Honz Pharmaceutical
Shandong DYNE Marine Biopharmaceutical
Sunflower Pharmaceutical
Jiangzhong Pharmaceutical
Yabao Pharmaceutical
Jumpcan Pharmaceutical
Hansen Pharmaceutical
| Report Attributes |
Report Details |
| Report Title |
Pediatric Gastrointestinal Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pediatric Gastrointestinal Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pediatric Gastrointestinal Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pediatric Gastrointestinal Drugs Overall Market Size
2.1 Global Pediatric Gastrointestinal Drugs Market Size: 2021 VS 2028
2.2 Global Pediatric Gastrointestinal Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pediatric Gastrointestinal Drugs Players in Global Market
3.2 Top Global Pediatric Gastrointestinal Drugs Companies Ranked by Revenue
3.3 Global Pediatric Gastrointestinal Drugs Revenue by Companies
3.4 Top 3 and Top 5 Pediatric Gastrointestinal Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pediatric Gastrointestinal Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pediatric Gastrointestinal Drugs Players in Global Market
3.6.1 List of Global Tier 1 Pediatric Gastrointestinal Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Pediatric Gastrointestinal Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Pediatric Gastrointestinal Drugs Market Size Markets, 2021 & 2028
4.1.2 Tablets
4.1.3 Pills
4.1.4 Oral Liquid
4.2 By Type - Global Pediatric Gastrointestinal Drugs Revenue & Forecasts
4.2.1 By Type - Global Pediatric Gastrointestinal Drugs Revenue, 2017-2022
4.2.2 By Type - Global Pediatric Gastrointestinal Drugs Revenue, 2023-2028
4.2.3 By Type - Global Pediatric Gastrointestinal Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pediatric Gastrointestinal Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Retail Pharmacies
5.2 By Application - Global Pediatric Gastrointestinal Drugs Revenue & Forecasts
5.2.1 By Application - Global Pediatric Gastrointestinal Drugs Revenue, 2017-2022
5.2.2 By Application - Global Pediatric Gastrointestinal Drugs Revenue, 2023-2028
5.2.3 By Application - Global Pediatric Gastrointestinal Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Pediatric Gastrointestinal Drugs Market Size, 2021 & 2028
6.2 By Region - Global Pediatric Gastrointestinal Drugs Revenue & Forecasts
6.2.1 By Region - Global Pediatric Gastrointestinal Drugs Revenue, 2017-2022
6.2.2 By Region - Global Pediatric Gastrointestinal Drugs Revenue, 2023-2028
6.2.3 By Region - Global Pediatric Gastrointestinal Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pediatric Gastrointestinal Drugs Revenue, 2017-2028
6.3.2 US Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.3.3 Canada Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.3.4 Mexico Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pediatric Gastrointestinal Drugs Revenue, 2017-2028
6.4.2 Germany Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.4.3 France Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.4.4 U.K. Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.4.5 Italy Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.4.6 Russia Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.4.8 Benelux Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pediatric Gastrointestinal Drugs Revenue, 2017-2028
6.5.2 China Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.5.3 Japan Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.5.4 South Korea Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.5.6 India Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pediatric Gastrointestinal Drugs Revenue, 2017-2028
6.6.2 Brazil Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.6.3 Argentina Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pediatric Gastrointestinal Drugs Revenue, 2017-2028
6.7.2 Turkey Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.7.3 Israel Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Pediatric Gastrointestinal Drugs Market Size, 2017-2028
6.7.5 UAE Pediatric Gastrointestinal Drugs Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Pediatric Gastrointestinal Drugs Major Product Offerings
7.1.4 AstraZeneca Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Pediatric Gastrointestinal Drugs Major Product Offerings
7.2.4 Sanofi Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 Aptalis
7.3.1 Aptalis Corporate Summary
7.3.2 Aptalis Business Overview
7.3.3 Aptalis Pediatric Gastrointestinal Drugs Major Product Offerings
7.3.4 Aptalis Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.3.5 Aptalis Key News
7.4 Eisai
7.4.1 Eisai Corporate Summary
7.4.2 Eisai Business Overview
7.4.3 Eisai Pediatric Gastrointestinal Drugs Major Product Offerings
7.4.4 Eisai Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.4.5 Eisai Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Pediatric Gastrointestinal Drugs Major Product Offerings
7.5.4 Pfizer Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.5.5 Pfizer Key News
7.6 Zeria (Tillotts)
7.6.1 Zeria (Tillotts) Corporate Summary
7.6.2 Zeria (Tillotts) Business Overview
7.6.3 Zeria (Tillotts) Pediatric Gastrointestinal Drugs Major Product Offerings
7.6.4 Zeria (Tillotts) Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.6.5 Zeria (Tillotts) Key News
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Corporate Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Pediatric Gastrointestinal Drugs Major Product Offerings
7.7.4 GlaxoSmithKline Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.7.5 GlaxoSmithKline Key News
7.8 Salix Pharmaceuticals
7.8.1 Salix Pharmaceuticals Corporate Summary
7.8.2 Salix Pharmaceuticals Business Overview
7.8.3 Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Major Product Offerings
7.8.4 Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.8.5 Salix Pharmaceuticals Key News
7.9 Perrigo
7.9.1 Perrigo Corporate Summary
7.9.2 Perrigo Business Overview
7.9.3 Perrigo Pediatric Gastrointestinal Drugs Major Product Offerings
7.9.4 Perrigo Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.9.5 Perrigo Key News
7.10 Abbott
7.10.1 Abbott Corporate Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Pediatric Gastrointestinal Drugs Major Product Offerings
7.10.4 Abbott Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.10.5 Abbott Key News
7.11 Honz Pharmaceutical
7.11.1 Honz Pharmaceutical Corporate Summary
7.11.2 Honz Pharmaceutical Business Overview
7.11.3 Honz Pharmaceutical Pediatric Gastrointestinal Drugs Major Product Offerings
7.11.4 Honz Pharmaceutical Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.11.5 Honz Pharmaceutical Key News
7.12 Shandong DYNE Marine Biopharmaceutical
7.12.1 Shandong DYNE Marine Biopharmaceutical Corporate Summary
7.12.2 Shandong DYNE Marine Biopharmaceutical Business Overview
7.12.3 Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Major Product Offerings
7.12.4 Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.12.5 Shandong DYNE Marine Biopharmaceutical Key News
7.13 Sunflower Pharmaceutical
7.13.1 Sunflower Pharmaceutical Corporate Summary
7.13.2 Sunflower Pharmaceutical Business Overview
7.13.3 Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Major Product Offerings
7.13.4 Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.13.5 Sunflower Pharmaceutical Key News
7.14 Jiangzhong Pharmaceutical
7.14.1 Jiangzhong Pharmaceutical Corporate Summary
7.14.2 Jiangzhong Pharmaceutical Business Overview
7.14.3 Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Major Product Offerings
7.14.4 Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.14.5 Jiangzhong Pharmaceutical Key News
7.15 Yabao Pharmaceutical
7.15.1 Yabao Pharmaceutical Corporate Summary
7.15.2 Yabao Pharmaceutical Business Overview
7.15.3 Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Major Product Offerings
7.15.4 Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.15.5 Yabao Pharmaceutical Key News
7.16 Jumpcan Pharmaceutical
7.16.1 Jumpcan Pharmaceutical Corporate Summary
7.16.2 Jumpcan Pharmaceutical Business Overview
7.16.3 Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Major Product Offerings
7.16.4 Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.16.5 Jumpcan Pharmaceutical Key News
7.17 Hansen Pharmaceutical
7.17.1 Hansen Pharmaceutical Corporate Summary
7.17.2 Hansen Pharmaceutical Business Overview
7.17.3 Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Major Product Offerings
7.17.4 Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Revenue in Global Market (2017-2022)
7.17.5 Hansen Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pediatric Gastrointestinal Drugs Market Opportunities & Trends in Global Market
Table 2. Pediatric Gastrointestinal Drugs Market Drivers in Global Market
Table 3. Pediatric Gastrointestinal Drugs Market Restraints in Global Market
Table 4. Key Players of Pediatric Gastrointestinal Drugs in Global Market
Table 5. Top Pediatric Gastrointestinal Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pediatric Gastrointestinal Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pediatric Gastrointestinal Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pediatric Gastrointestinal Drugs Product Type
Table 9. List of Global Tier 1 Pediatric Gastrointestinal Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pediatric Gastrointestinal Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pediatric Gastrointestinal Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pediatric Gastrointestinal Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pediatric Gastrointestinal Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pediatric Gastrointestinal Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pediatric Gastrointestinal Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pediatric Gastrointestinal Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Pediatric Gastrointestinal Drugs Product Offerings
Table 32. AstraZeneca Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Pediatric Gastrointestinal Drugs Product Offerings
Table 35. Sanofi Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Aptalis Corporate Summary
Table 37. Aptalis Pediatric Gastrointestinal Drugs Product Offerings
Table 38. Aptalis Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Eisai Corporate Summary
Table 40. Eisai Pediatric Gastrointestinal Drugs Product Offerings
Table 41. Eisai Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Pediatric Gastrointestinal Drugs Product Offerings
Table 44. Pfizer Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Zeria (Tillotts) Corporate Summary
Table 46. Zeria (Tillotts) Pediatric Gastrointestinal Drugs Product Offerings
Table 47. Zeria (Tillotts) Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline Pediatric Gastrointestinal Drugs Product Offerings
Table 50. GlaxoSmithKline Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Salix Pharmaceuticals Corporate Summary
Table 52. Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Product Offerings
Table 53. Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Perrigo Corporate Summary
Table 55. Perrigo Pediatric Gastrointestinal Drugs Product Offerings
Table 56. Perrigo Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Abbott Corporate Summary
Table 58. Abbott Pediatric Gastrointestinal Drugs Product Offerings
Table 59. Abbott Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Honz Pharmaceutical Corporate Summary
Table 61. Honz Pharmaceutical Pediatric Gastrointestinal Drugs Product Offerings
Table 62. Honz Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Shandong DYNE Marine Biopharmaceutical Corporate Summary
Table 64. Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Product Offerings
Table 65. Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Sunflower Pharmaceutical Corporate Summary
Table 67. Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Product Offerings
Table 68. Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Jiangzhong Pharmaceutical Corporate Summary
Table 70. Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Product Offerings
Table 71. Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 72. Yabao Pharmaceutical Corporate Summary
Table 73. Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Product Offerings
Table 74. Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 75. Jumpcan Pharmaceutical Corporate Summary
Table 76. Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Product Offerings
Table 77. Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
Table 78. Hansen Pharmaceutical Corporate Summary
Table 79. Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Product Offerings
Table 80. Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Pediatric Gastrointestinal Drugs Segment by Type in 2021
Figure 2. Pediatric Gastrointestinal Drugs Segment by Application in 2021
Figure 3. Global Pediatric Gastrointestinal Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pediatric Gastrointestinal Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pediatric Gastrointestinal Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pediatric Gastrointestinal Drugs Revenue in 2021
Figure 8. By Type - Global Pediatric Gastrointestinal Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pediatric Gastrointestinal Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pediatric Gastrointestinal Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pediatric Gastrointestinal Drugs Revenue Market Share, 2017-2028
Figure 12. US Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pediatric Gastrointestinal Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pediatric Gastrointestinal Drugs Revenue Market Share, 2017-2028
Figure 24. China Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pediatric Gastrointestinal Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pediatric Gastrointestinal Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pediatric Gastrointestinal Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Aptalis Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eisai Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Zeria (Tillotts) Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Perrigo Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Abbott Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Honz Pharmaceutical Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
